北京商报讯（记者 丁宁）8月20日晚间，泰恩康（301263）披露2025年半年度报告显示，上半年，公司 实现营业收入3.47亿元，同比下降12.23%；归属净利润3708.48万元，同比下降56.75%。 泰恩康表示，面对内外部环境的变化与挑战，公司核心板块肠胃用药的销售收入实现增长，两性健康用 药和眼科用药的销售收入有所下滑。其中，肠胃用药实现销售收入10338.86万元，同比增长11.04%；眼 科用药实现销售收入7938.35万元，同比减少9.02%；两性健康用药因竞品数量持续增加，市场竞争激烈 等因素导致销售收入有所下滑，报告期内实现销售收入6674.4万元，同比减少48.75%。 ...

Core Viewpoint - Eye health is a comprehensive concept that goes beyond just having good vision, encompassing various dimensions such as visual acuity, visual field, contrast sensitivity, and visual quality [1][2] Group 1: Current Challenges in Eye Health - The three major challenges in eye health include the increasing prevalence of myopia among younger populations, the widespread occurrence of dry eye disease, and the commonality of visual fatigue combined with chronic inflammation [2] - There is a growing demand for eye disease treatment across all age groups in China, driven by the increasing awareness of eye health issues [1] Group 2: Public Awareness and Misconceptions - There are three main misconceptions among the public regarding eye health: parents overly focus on children's myopia while neglecting other conditions like strabismus and amblyopia; office workers often consider visual fatigue as normal and neglect regular professional check-ups; and older adults mistakenly view presbyopia as a natural aging process, delaying treatment for conditions like cataracts [2] - The demand for eye-related consultations on the JD Health platform has reached over 10,000 daily inquiries, indicating a significant public interest in eye health [2] Group 3: Consumer Behavior and Treatment Trends - Consumers are showing a high frequency and diversity in their demand for ophthalmic medications, but adherence to treatment remains a challenge due to long treatment cycles and difficulty in changing eye care habits [3] - The use of online channels, particularly internet hospitals, is accelerating the process for users from understanding to researching and purchasing ophthalmic medications, with a reported increase in consultation rates by over 20% and a reduction in consultation intervals from 4.3 months to 2.8 months [3]